Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

LOC401317 Activators

LOC401317 Activators would imply a group of molecules that are capable of enhancing the activity of the protein product of the LOC401317 gene locus. These activators would have a specific affinity for the LOC401317 protein and would interact with it in a manner that increases its natural or baseline activity. The mechanisms by which these compounds would activate LOC401317 could be diverse, potentially involving direct binding to the protein to induce a conformational change that promotes activity, binding at allosteric sites to modulate function, or even affecting the levels of the protein by influencing gene expression, mRNA stability, or protein degradation pathways. Identification of such activators would likely involve high-throughput screening assays where various chemical compounds are tested for their ability to increase the activity of LOC401317, followed by a series of secondary assays to confirm and quantify the activation.

Diving deeper into the characterization of LOC401317 Activators, subsequent research would likely focus on the interaction dynamics between these molecules and the LOC401317 protein. Detailed biochemical studies would be conducted to assess the binding affinity and selectivity of these activators, utilizing techniques such as equilibrium dialysis, fluorescence polarization, or surface plasmon resonance (SPR). In conjunction with these, structural studies would be imperative to visualize how these activators interact with LOC401317, potentially employing methods like X-ray crystallography, NMR spectroscopy, or cryo-electron microscopy to obtain high-resolution structures of the protein both with and without the activator bound. These studies would reveal the precise binding sites and the structural changes upon activation, providing insights into the mechanism of action at a molecular level. Furthermore, computational approaches such as molecular docking and molecular dynamics simulations could predict interactions and suggest modifications to improve the efficacy of these activators. Through iterative cycles of design, synthesis, and testing, a comprehensive profile of the activators' effects on LOC401317 would be constructed. This would not only enhance the understanding of the protein's function but would also contribute to a broader appreciation of how small molecules can modulate protein activity.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rolipram

61413-54-5sc-3563
sc-3563A
5 mg
50 mg
$77.00
$216.00
18
(1)

Rolipram is a phosphodiesterase inhibitor, which increases cAMP levels, and may consequently enhance CREB5 expression through CRE-mediated gene transcription.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$260.00
$350.00
$500.00
34
(1)

IBMX is a non-selective inhibitor of phosphodiesterases, leading to increased cAMP and potentially upregulated CREB5 expression.

PGE2

363-24-6sc-201225
sc-201225C
sc-201225A
sc-201225B
1 mg
5 mg
10 mg
50 mg
$57.00
$159.00
$275.00
$678.00
37
(1)

PGE2 binds to its receptors and can activate adenylate cyclase, leading to increased cAMP and possible induction of CREB5 expression.

Dibutyryl-cAMP

16980-89-5sc-201567
sc-201567A
sc-201567B
sc-201567C
20 mg
100 mg
500 mg
10 g
$47.00
$136.00
$492.00
$4552.00
74
(7)

db-cAMP is a cAMP analog that can mimic the action of endogenous cAMP and may upregulate CREB5 expression.

(−)-Epinephrine

51-43-4sc-205674
sc-205674A
sc-205674B
sc-205674C
sc-205674D
1 g
5 g
10 g
100 g
1 kg
$41.00
$104.00
$201.00
$1774.00
$16500.00
(1)

Epinephrine activates adenylyl cyclase via G protein-coupled receptors, increasing intracellular cAMP and potentially enhancing CREB5 expression.

Adenosine

58-61-7sc-291838
sc-291838A
sc-291838B
sc-291838C
sc-291838D
sc-291838E
sc-291838F
1 g
5 g
100 g
250 g
1 kg
5 kg
10 kg
$34.00
$48.00
$300.00
$572.00
$1040.00
$2601.00
$4682.00
1
(0)

Adenosine can activate adenylyl cyclase through its A2 receptors, increasing cAMP levels and possibly CREB5 expression.

Theophylline

58-55-9sc-202835
sc-202835A
sc-202835B
5 g
25 g
100 g
$20.00
$32.00
$85.00
6
(0)

Theophylline is another non-specific phosphodiesterase inhibitor that raises cAMP levels and may influence CREB5 expression.

Caffeine

58-08-2sc-202514
sc-202514A
sc-202514B
sc-202514C
sc-202514D
50 g
100 g
250 g
1 kg
5 kg
$33.00
$67.00
$97.00
$192.00
$775.00
13
(1)

Caffeine, similar to theophylline, inhibits phosphodiesterases leading to increased cAMP and potential upregulation of CREB5.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol is a beta-adrenergic agonist that can increase cAMP and thereby potentially induce CREB5 expression.